Palisade Bio (PALI) Profit After Tax (2010 - 2026)

Palisade Bio (PALI) has reported Profit After Tax for 17 consecutive years, with -$9.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Profit After Tax fell 330.49% year-over-year to -$9.6 million; the TTM figure through Mar 2026 stood at -$24.2 million (down 83.78% YoY), while the FY2025 annual figure was -$16.8 million, down 16.23% from the prior year.
• Profit After Tax retreated to -$9.6 million in Q1 2026 per PALI's latest filing, from -$8.9 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$2.2 million in Q1 2025 and bottomed at -$9.6 million in Q1 2026.
• Historically, Profit After Tax has averaged -$4.0 million across 5 years, with a median of -$3.5 million in 2024.
• On a YoY basis, Profit After Tax climbed as much as 92.62% in 2022 and fell as far as 446.69% in 2022.
• Palisade Bio's Profit After Tax stood at -$3.7 million in 2022, then increased by 20.13% to -$3.0 million in 2023, then retreated by 12.55% to -$3.3 million in 2024, then slumped by 166.12% to -$8.9 million in 2025, then decreased by 7.88% to -$9.6 million in 2026.
• Business Quant data shows PALI's Profit After Tax at -$9.6 million in Q1 2026, -$8.9 million in Q4 2025, and -$2.9 million in Q3 2025.